rs118203981
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_148960.3(CLDN19):c.269T>G(p.Leu90Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L90P) has been classified as Pathogenic.
Frequency
Consequence
NM_148960.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CLDN19 | NM_148960.3 | c.269T>G | p.Leu90Arg | missense_variant | 2/5 | ENST00000296387.6 | |
CLDN19 | NM_001185117.2 | c.269T>G | p.Leu90Arg | missense_variant | 2/3 | ||
CLDN19 | NM_001123395.2 | c.269T>G | p.Leu90Arg | missense_variant | 2/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CLDN19 | ENST00000296387.6 | c.269T>G | p.Leu90Arg | missense_variant | 2/5 | 2 | NM_148960.3 | ||
CLDN19 | ENST00000372539.3 | c.269T>G | p.Leu90Arg | missense_variant | 2/4 | 1 | P1 | ||
CLDN19 | ENST00000539749.5 | c.269T>G | p.Leu90Arg | missense_variant | 2/3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Renal hypomagnesemia 5 with ocular involvement Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | 3billion | Jan 03, 2022 | The variant was co-segregated with Hypomagnesemia 5, renal, with ocular involvement in multiple affected family members with additional meioses meeting (PMID: 27530400, PP1_M).The variant has been reported to be in trans with a pathogenic variant as either compound heterozygous or homozygous in at least one similarly affected unrelated individual (PMID: 27530400, PM3_M). A different missense change at the same codon has been reported to be associated with CLDN19 related disorder (ClinVar ID: VCV000001363, PMID:17033971, PM5_P). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.955, 3CNET: 0.839, PP3_P). A missense variant is a common mechanism associated with Hypomagnesemia 5 (PP2_P). It is not observed in the gnomAD v2.1.1 dataset (PM2_M). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 10, 2018 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 29, 2021 | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 548636). This missense change has been observed in individuals with familial hypomagnesemia with hypercalciuria and nephrocalcinosis (PMID: 27530400). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (ExAC no frequency). This sequence change replaces leucine with arginine at codon 90 of the CLDN19 protein (p.Leu90Arg). The leucine residue is highly conserved and there is a moderate physicochemical difference between leucine and arginine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at